Agency
South Shore Hospital INC.
South Shore Hospital INC. was paid $7.88M by Medicaid between Jan 2018 and Dec 2024, across 83 billing codes. Its largest line is G0299, Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes — 58% of everything it billed.
33Billing provider infoSOUTH SHORE HOSPITAL INC.
BRAINTREE, MA 02184
BRAINTREE, MA 02184
33aNPI1669558474assigned 10/27/2006
33bProvider typeHome Health Agency
28Total paid$7.88M
24GClaims120,421
24DCodes billed83
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Home Health Agency providers in Massachusetts
Rank by total paid#93 of 299
Median peer was paid$2.39M
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,117 | $632K | |
| 2019 | 24,932 | $1.76M | |
| 2020 | 25,973 | $1.66M | |
| 2021 | 18,995 | $1.19M | |
| 2022 | 16,535 | $1.29M | |
| 2023 | 13,129 | $857K | |
| 2024incomplete | 7,740 | $484K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | 58% | 59,094 | 15,317 | $4.58M |
| G0151 | Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes | 15% | 20,133 | 5,660 | $1.22M |
| G0152 | Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes | 5.8% | 7,337 | 2,451 | $457K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.6% | 1,535 | 1,477 | $362K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.9% | 937 | 907 | $229K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 529 | 488 | $176K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.8% | 592 | 578 | $138K |
| S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | 1.6% | 7,600 | 2,247 | $129K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.5% | 559 | 180 | $115K |
| S9131 | Physical therapy; in the home, per diem | 1.0% | 4,713 | 1,318 | $81K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 337 | 334 | $73K |
| G0300 | Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes | <1% | 1,128 | 615 | $67K |
71 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 133 | $30K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 204 | $22K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 75 | $18K |
| 59025 | Fetal non-stress test | <1% | 70 | $17K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 133 | $17K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 109 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 143 | $16K |
| S9129 | Occupational therapy, in the home, per diem | <1% | 1,085 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 424 | $12K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 311 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 1,197 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,417 | $7K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 71 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 228 | $6K |
| G0156 | Services of home health/hospice aide in home health or hospice settings, each 15 minutes | <1% | 613 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 34 | $6K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 12 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 474 | $5K |
| J3490 | Unclassified drugs | <1% | 81 | $4K |
| A0425 | Ground mileage, per statute mile | <1% | 230 | $4K |
| 84484 | <1% | 313 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $2K |
| 84702 | <1% | 199 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 270 | $2K |
| 81025 | <1% | 363 | $2K | |
| 83690 | <1% | 356 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 213 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 61 | $898.27 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 27 | $732.34 |
| 81001 | <1% | 350 | $725.78 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 662 | $690.22 |
| 83735 | <1% | 130 | $612.28 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 109 | $592.27 |
| 85027 | <1% | 120 | $561.54 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 200 | $482.50 |
| 81003 | <1% | 303 | $449.31 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 37 | $448.14 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 37 | $448.14 |
| 85610 | <1% | 167 | $447.22 | |
| 86141 | <1% | 45 | $427.24 | |
| 86850 | <1% | 72 | $423.24 | |
| 85379 | <1% | 50 | $374.54 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 212 | $368.57 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 513 | $324.66 |
| 87070 | <1% | 49 | $272.85 | |
| 87081 | <1% | 96 | $266.84 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 436 | $237.84 |
| 87040 | <1% | 25 | $236.92 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 807 | $209.36 |
| 86901 | <1% | 84 | $188.63 | |
| 86900 | <1% | 84 | $188.63 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 176 | $184.06 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 294 | $182.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 102 | $168.75 |
| 96376 | <1% | 32 | $155.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 35 | $135.44 |
| 87205 | <1% | 37 | $125.36 | |
| 85652 | <1% | 56 | $114.06 | |
| 71045 | Radiologic examination, chest; single view | <1% | 59 | $113.47 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 81 | $100.87 |
| 74019 | <1% | 12 | $77.77 | |
| 85007 | <1% | 35 | $71.99 | |
| J2704 | Injection, propofol, 10 mg | <1% | 67 | $63.31 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 181 | $59.87 |
| 83605 | <1% | 14 | $58.50 | |
| 87420 | <1% | 17 | $32.82 | |
| 82962 | <1% | 121 | $31.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 360 | $25.48 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 101 | $4.04 |
| 1111F | 0% | 689 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPASCARELLI, RICHARD (FINANCE MANAGER)
Parent organizationSOUTH SHORE HOSPITAL INC.